Price Target Analysis Eleven Biotherapeutics, Inc. (EBIO)

0
40

The Relative Volume of the company is 2.13 and Average Volume (3 months) is 891.97 million.

The company shows its Return on Assets (ROA) value of -28.1%. The Return on Equity (ROE) value stands at -90.8%. While it’s Return on Investment (ROI) value is 7.4%.

While looking at the Stock’s Performance, Eleven Biotherapeutics, Inc. currently shows a Weekly Performance of 2.85%, where Monthly Performance is 0.58%, Quarterly performance is -58.86%, 6 Months performance is -52.2% and yearly performance percentage is -71.83%. Year to Date performance value (YTD perf) value is -64.46%. The Stock currently has a Weekly Volatility of 9.43% and Monthly Volatility of 8.62%.